VLPNA

Leticia Guzman Ruiz1, Alexander M Zollner2, Irene Hoxie3

  • 1University of Natural Resources and Life Sciences Vienna (BOKU), Department of Biotechnology, Institute of Molecular Biotechnology (IMBT), Muthgasse 18, 1190 Vienna, Austria; University of Natural Resources and Life Sciences Vienna (BOKU), Department of Biotechnology, Institute of Bioprocess Science and Engineering (IBSE), Muthgasse 18, 1190 Vienna, Austria.

Vaccine
|August 28, 2024
PubMed
概括

下一代流感疫苗可以通过增强神经氨基酶 (NA) 免疫性来改进. 修改血凝素 (HA):NA比率并将NA茎扩展到类似病毒的粒子 (VLPs) 上,成功地引起了NA-反应性抗体.